Major Depressive Disorder affects 13% of the population of the U.S. and is the leading cause of disability in patients aged 15-44.
Show Notes
Major Depressive Disorder is typically treated by anti-depressants and with psychotherapy, but there are challenges with these treatments including relapse and side-effects. The study reviewed in this podcast looks at trans-cranial laser therapy, from childhood through elderliness, by simulating how dosage and wavelengths affect trans-cranial photobiomodulation, for treatment of various neuropsychiatric disorders such as MDD, addiction, anxiety, and more.
Study mentioned in this episode:
What is Healing at the Speed of Light?
Each week we discuss how laser therapy is changing healthcare and how you can benefit.